US gross order intake and customer base grew sharply in Q3 2025, driving improved financial results and reduced losses. Regulatory progress for the MTP implant continues, with a focus on US market expansion and cost-saving measures. Material uncertainty remains due to unsecure near-term financing.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.